Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1955 1
1956 2
1957 2
1958 1
1959 2
1960 2
1963 3
1964 11
1965 27
1966 19
1967 21
1968 37
1969 25
1970 34
1971 46
1972 51
1973 48
1974 31
1975 56
1976 51
1977 67
1978 48
1979 49
1980 63
1981 43
1982 59
1983 67
1984 85
1985 81
1986 83
1987 102
1988 102
1989 114
1990 137
1991 119
1992 145
1993 156
1994 102
1995 125
1996 132
1997 130
1998 166
1999 158
2000 193
2001 198
2002 211
2003 222
2004 215
2005 260
2006 262
2007 281
2008 314
2009 373
2010 380
2011 411
2012 464
2013 507
2014 582
2015 648
2016 696
2017 703
2018 698
2019 820
2020 839
2021 974
2022 852
2023 704
2024 333

Text availability

Article attribute

Article type

Publication date

Search Results

13,415 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 4"
Page 1
Idiopathic pulmonary fibrosis.
Richeldi L, Collard HR, Jones MG. Richeldi L, et al. Lancet. 2017 May 13;389(10082):1941-1952. doi: 10.1016/S0140-6736(17)30866-8. Epub 2017 Mar 30. Lancet. 2017. PMID: 28365056 Review.
Idiopathic pulmonary fibrosis is a prototype of chronic, progressive, and fibrotic lung disease. ...In this Seminar, we summarise the presentation, pathophysiology, diagnosis, and treatment options available for patients with idiopathic pulmonary fibrosis …
Idiopathic pulmonary fibrosis is a prototype of chronic, progressive, and fibrotic lung disease. ...In this Seminar, we summar …
Progressive pulmonary fibrosis: an expert group consensus statement.
Rajan SK, Cottin V, Dhar R, Danoff S, Flaherty KR, Brown KK, Mohan A, Renzoni E, Mohan M, Udwadia Z, Shenoy P, Currow D, Devraj A, Jankharia B, Kulshrestha R, Jones S, Ravaglia C, Quadrelli S, Iyer R, Dhooria S, Kolb M, Wells AU. Rajan SK, et al. Eur Respir J. 2023 Mar 30;61(3):2103187. doi: 10.1183/13993003.03187-2021. Print 2023 Mar. Eur Respir J. 2023. PMID: 36517177 Free PMC article. Review.
The value of diagnostic tests in risk stratification at presentation and, separately, the importance of a logical monitoring strategy, tailored to manage the risk of progression, are also stressed. The term "progressive pulmonary fibrosis" (PPF) exactly describes th …
The value of diagnostic tests in risk stratification at presentation and, separately, the importance of a logical monitoring strategy, tailo …
Idiopathic pulmonary fibrosis.
Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, Swigris JJ, Taniguchi H, Wells AU. Martinez FJ, et al. Nat Rev Dis Primers. 2017 Oct 20;3:17074. doi: 10.1038/nrdp.2017.74. Nat Rev Dis Primers. 2017. PMID: 29052582 Review.
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by progressive lung scarring and the histological picture of usual interstitial pneumonia (UIP). ...
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by progressive lung scarring and the …
Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis.
Meyer KC. Meyer KC. Expert Rev Respir Med. 2017 May;11(5):343-359. doi: 10.1080/17476348.2017.1312346. Epub 2017 Apr 10. Expert Rev Respir Med. 2017. PMID: 28345383 Review.
Many forms of interstitial lung disease (ILD) can progress to extensive fibrosis and respiratory failure. Idiopathic pulmonary fibrosis (IPF), which generally has a poor prognosis, has been thoroughly studied over the past two decades, and many importa …
Many forms of interstitial lung disease (ILD) can progress to extensive fibrosis and respiratory failure. Idiopathic pulmon …
Pulmonary fibrosis: from pathogenesis to clinical decision-making.
Koudstaal T, Funke-Chambour M, Kreuter M, Molyneaux PL, Wijsenbeek MS. Koudstaal T, et al. Trends Mol Med. 2023 Dec;29(12):1076-1087. doi: 10.1016/j.molmed.2023.08.010. Epub 2023 Sep 14. Trends Mol Med. 2023. PMID: 37716906 Review.
Pulmonary fibrosis (PF) encompasses a spectrum of chronic lung diseases that progressively impact the interstitium, resulting in compromised gas exchange, breathlessness, diminished quality of life (QoL), and ultimately respiratory failure and mortality. ...T …
Pulmonary fibrosis (PF) encompasses a spectrum of chronic lung diseases that progressively impact the interstitium, resulting …
Developmental pathways in the pathogenesis of lung fibrosis.
Chanda D, Otoupalova E, Smith SR, Volckaert T, De Langhe SP, Thannickal VJ. Chanda D, et al. Mol Aspects Med. 2019 Feb;65:56-69. doi: 10.1016/j.mam.2018.08.004. Epub 2018 Aug 23. Mol Aspects Med. 2019. PMID: 30130563 Free PMC article. Review.
Idiopathic pulmonary fibrosis (IPF) is a progressive and terminal lung disease with no known cure. ...In this review, we analyze current knowledge in the field, gained from both basic and clinical research, to provide new insights into the disease process, and poten …
Idiopathic pulmonary fibrosis (IPF) is a progressive and terminal lung disease with no known cure. ...In this review, we analy …
Idiopathic pulmonary fibrosis.
King TE Jr, Pardo A, Selman M. King TE Jr, et al. Lancet. 2011 Dec 3;378(9807):1949-61. doi: 10.1016/S0140-6736(11)60052-4. Epub 2011 Jun 28. Lancet. 2011. PMID: 21719092 Review.
Idiopathic pulmonary fibrosis is a devastating, age-related lung disease of unknown cause that has few treatment options. ...In this Seminar, we review recent data on the clinical course, therapeutic options, and underlying mechanisms thought to be involved in the p …
Idiopathic pulmonary fibrosis is a devastating, age-related lung disease of unknown cause that has few treatment options. ...I …
Idiopathic Pulmonary Fibrosis: Epidemiology, Diagnosis andOutcomes.
Wakwaya Y, Brown KK. Wakwaya Y, et al. Am J Med Sci. 2019 May;357(5):359-369. doi: 10.1016/j.amjms.2019.02.013. Epub 2019 Feb 15. Am J Med Sci. 2019. PMID: 31010461 Review.
The incidence and prevalence of idiopathic pulmonary fibrosis (IPF) is increasing worldwide. This, combined with its poor prognosis and unpredictable natural history, has amplified the importance of an accurate diagnosis and monitoring. ...
The incidence and prevalence of idiopathic pulmonary fibrosis (IPF) is increasing worldwide. This, combined with its poor prog …
Spectrum of Fibrotic Lung Diseases.
Wijsenbeek M, Cottin V. Wijsenbeek M, et al. N Engl J Med. 2020 Sep 3;383(10):958-968. doi: 10.1056/NEJMra2005230. N Engl J Med. 2020. PMID: 32877584 Review. No abstract available.
Idiopathic pulmonary fibrosis.
Koudstaal T, Wijsenbeek MS. Koudstaal T, et al. Presse Med. 2023 Sep;52(3):104166. doi: 10.1016/j.lpm.2023.104166. Epub 2023 May 6. Presse Med. 2023. PMID: 37156412 Free article. Review.
Idiopathic pulmonary fibrosis (IPF) is a progressive devastating lung disease with substantial morbidity. ...IPF affects 3 million people worldwide, with increasing incidence in older patients. The current concept of pathogenesis is that pulmonary fibrosis …
Idiopathic pulmonary fibrosis (IPF) is a progressive devastating lung disease with substantial morbidity. ...IPF affects 3 mil …
13,415 results
You have reached the last available page of results. Please see the User Guide for more information.